Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2013
11/06/2013CN101835772B Novel imidazole derivatives
11/06/2013CN101657423B Iminipyridine derivatives and their uses as microbiocides
11/06/2013CN101641346B Pyridine and pyrimidine derivatives as mglur2 antagonists
11/06/2013CN101522659B Fungicide N-cycloalkyl-carboxamide, thiocarboxamide and N-substituted-carboximidamide derivatives
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575197 Pyrolinone derivative and pharmaceutical composition comprising the same
11/05/2013US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575118 Antiviral compounds
10/2013
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013162284A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/31/2013WO2013162046A1 Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
10/31/2013WO2013161871A1 Thiophene derivative having tlr-inhibiting activity
10/31/2013WO2013161816A1 Amine compound and use thereof for medical purposes
10/31/2013US20130289073 Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
10/31/2013US20130289057 N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease
10/31/2013US20130289041 Quinoxaline compounds and uses thereof
10/31/2013US20130289033 Novel compounds for the treatment of neurodegenerative diseases
10/30/2013EP2657227A1 Novel substituted isoquinoline derivative
10/30/2013EP2657225A2 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
10/30/2013EP2655367A1 N-substituted azetidine derivatives
10/30/2013EP2655366A1 Naphtalene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2655347A1 Triazine derivatives for electronic applications
10/30/2013CN103380508A Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element
10/30/2013CN103380123A Novel carboxamide microbiocides
10/30/2013CN103380122A Novel benzodioxole piperazine compounds
10/30/2013CN103380117A Picolinamide inhibitors of kinases
10/30/2013CN103373990A Chromophore molecule containing triptycene rigid stereochemical structure, and synthetic method and application thereof
10/30/2013CN103373988A 1, 2, 4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN102471306B Microbiocides
10/30/2013CN102276593B Heterocyclic ketene hydrazone compound and preparation method as well as tubercle bacillus resistant application
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569312 Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
10/29/2013US8569302 Inhibitors of flaviviridae viruses
10/29/2013CA2603254C New bicyclic angiotensin ii agonists
10/29/2013CA2558615C Azabicyclo-octane inhibitors of iap
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013157886A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013156936A1 Process for the preparation of rivaroxaban and intermediates thereof
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013156559A1 N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
10/24/2013WO2013156318A1 Substituted pesticidal pyrazole compounds
10/24/2013US20130281505 Pyrazol-4-yl carboxamide derivatives as microbiocides
10/24/2013US20130281490 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA)
10/24/2013US20130281453 Anti-cancer serine hydrolase inhibitory carbamates
10/24/2013US20130281451 Indolin-2-one derivatives as protein kinase inhibitors
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281392 Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2652003A1 Carboxylation of poly-/oligothiophenes
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651926A2 Anti-viral compounds
10/23/2013EP2651923A1 Anti-viral compounds
10/23/2013EP2651913A1 Indeno- fused ring compounds having photochromic properties
10/23/2013EP2651911A1 Lactone compounds and materials made therefrom
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651888A1 New compounds for the treatment of neurodegenerative diseases
10/23/2013CN103370808A 有机电致发光装置 Organic electroluminescent device
10/23/2013CN103370312A 1,3-dioxan-5-one compounds
10/23/2013CN103370307A Sulphonamide compounds and methods of making and using same
10/23/2013CN103369962A 5-halogenopyrazole(thio)carboxamides
10/23/2013CN103360376A Method for preparing 17 beta-HSD1 inhibitor
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102372532B Palladium-catalyzed ortho-orientation nitrification method of aza calixarene compounds
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/22/2013US8563779 (4-trifluoromethyl-3-thiobenzoyl)cyclohexanediones and use thereof as herbicides
10/22/2013US8563747 Processes for the alkylation of pyrazoles
10/22/2013US8563746 Cyclic benzimidazole derivatives useful as anti-diabetic agents
10/22/2013US8563596 Enantiomerically pure compounds for the treatment of proliferative disorders
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/17/2013WO2013154325A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013US20130274481 Process for the preparation of 3-haloalkylpyrazoles
10/17/2013US20130274320 Chromone Inhibitors of S-Nitrosoglutathione Reductase
10/17/2013US20130274283 Premature-termination-codons readthrough compounds
10/17/2013US20130274260 New compounds for the treatment of neurodegenerative diseases
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130273569 Violet laser excitable dyes and their method of use
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/16/2013EP2650941A1 Organic electroluminescent element
10/16/2013EP2649052A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
10/16/2013EP2649051A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
10/16/2013EP2648516A1 Substituted pyridinone-pyridinyl compounds
10/16/2013CN103351384A Preparing method for tiagabine hydrochloride
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 523